ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 437 filers reported holding ENCOMPASS HEALTH CORP in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $441,443 | +0.8% | 6,573 | +1.6% | 0.00% | 0.0% |
Q2 2023 | $438,151 | +51.9% | 6,471 | +21.4% | 0.00% | 0.0% |
Q1 2023 | $288,461 | +1.7% | 5,332 | +12.5% | 0.00% | 0.0% |
Q4 2022 | $283,559 | -15.9% | 4,741 | -36.4% | 0.00% | 0.0% |
Q3 2022 | $337,000 | -33.1% | 7,455 | -17.1% | 0.00% | 0.0% |
Q2 2022 | $504,000 | -11.4% | 8,996 | +12.4% | 0.00% | 0.0% |
Q1 2022 | $569,000 | +9.0% | 8,001 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $522,000 | -3.2% | 8,001 | +11.3% | 0.00% | 0.0% |
Q3 2021 | $539,000 | -21.9% | 7,189 | -16.3% | 0.00% | 0.0% |
Q2 2021 | $690,000 | -8.0% | 8,589 | -5.3% | 0.00% | -50.0% |
Q1 2021 | $750,000 | -8.1% | 9,070 | -8.1% | 0.00% | 0.0% |
Q4 2020 | $816,000 | +15.6% | 9,868 | -9.2% | 0.00% | 0.0% |
Q3 2020 | $706,000 | +25.6% | 10,868 | +19.9% | 0.00% | +100.0% |
Q2 2020 | $562,000 | -7.3% | 9,068 | -4.2% | 0.00% | -50.0% |
Q1 2020 | $606,000 | -7.6% | 9,468 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $656,000 | +9.5% | 9,468 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $599,000 | – | 9,468 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
RK Capital | 179,800 | $13,492,000 | 2.55% |
Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |